AXSOME THERAPEUTICS, INC. Investing Cash Flow
AXSOME THERAPEUTICS, INC. (AXSM) reported Investing Cash Flow of -$571.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$450.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$121.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$71.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$58.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$480.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$270.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$582.00K.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$53.70M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$571.00K 10-Q · filed 2026-08-10 | -$642.00K derived: sum of 3 quarters · filed 2026-08-10 | -$700.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$121.00K 10-Q · filed 2026-05-04 | -$192.00K derived: sum of 2 quarters · filed 2026-05-04 | -$250.00K derived: sum of 3 quarters · filed 2026-05-04 | -$263.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$129.00K derived: sum of 2 quarters · filed 2026-02-23 | -$142.00K derived: sum of 3 quarters · filed 2026-08-10 | -$480.00K 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$71.00K derived: sum of 2 quarters · filed 2026-08-10 | -$409.00K 10-Q · filed 2025-11-03 | -$439.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$351.00K 10-Q · filed 2026-08-10 | -$381.00K derived: sum of 3 quarters · filed 2026-08-10 | -$471.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$338.00K 10-Q · filed 2026-05-04 | -$368.00K derived: sum of 2 quarters · filed 2026-05-04 | -$458.00K derived: sum of 3 quarters · filed 2026-05-04 | -$510.00K derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$120.00K derived: sum of 2 quarters · filed 2026-02-23 | -$172.00K derived: sum of 3 quarters · filed 2026-02-23 | -$270.00K 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$142.00K derived: sum of 2 quarters · filed 2025-11-03 | -$240.00K 10-Q · filed 2025-11-03 | -$247.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$150.00K 10-Q · filed 2025-08-04 | -$157.00K derived: sum of 3 quarters · filed 2026-02-23 | -$528.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | -$98.00K 10-Q · filed 2025-05-05 | -$105.00K derived: sum of 2 quarters · filed 2026-02-23 | -$476.00K derived: sum of 3 quarters · filed 2026-02-23 | -$609.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$378.00K derived: sum of 2 quarters · filed 2026-02-23 | -$511.00K derived: sum of 3 quarters · filed 2026-02-23 | -$582.00K 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | -$371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$504.00K derived: sum of 2 quarters · filed 2024-11-12 | -$575.00K 10-Q · filed 2024-11-12 | -$756.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$204.00K 10-Q · filed 2024-08-05 | -$385.00K derived: sum of 3 quarters · filed 2025-02-18 | -$451.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | -$71.00K 10-Q · filed 2024-05-06 | -$252.00K derived: sum of 2 quarters · filed 2025-02-18 | -$318.00K derived: sum of 3 quarters · filed 2025-02-18 | -$53.56M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | -$181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$247.00K derived: sum of 2 quarters · filed 2025-02-18 | -$53.49M derived: sum of 3 quarters · filed 2025-02-18 | -$53.70M 10-K · filed 2025-02-18 | -$53.70M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$53.31M derived: sum of 2 quarters · filed 2023-11-06 | -$53.52M 10-Q · filed 2023-11-06 | -$53.52M 10-Q · filed 2022-11-07 | -$53.52M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | -$53.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$53.45M 10-Q · filed 2023-08-07 | -$53.46M 10-Q · filed 2022-08-09 | -$53.46M derived: sum of 3 quarters · filed 2024-02-23 | -$53.71M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | -$214.00K 10-Q · filed 2023-05-09 | -$213.74K 10-Q · filed 2022-05-02 | -$214.45K derived: sum of 2 quarters · filed 2024-02-23 | -$473.13K derived: sum of 3 quarters · filed 2024-02-23 | -$492.00K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | -$451.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$259.13K derived: sum of 2 quarters · filed 2024-02-23 | -$278.00K derived: sum of 3 quarters · filed 2024-02-23 | -$308.00K 10-K · filed 2024-02-23 | -$307.55K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$258.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$277.55K derived: sum of 2 quarters · filed 2022-11-07 | -$307.55K 10-Q · filed 2022-11-07 | -$327.84K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$18.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$48.87K 10-Q · filed 2022-08-09 | -$69.16K derived: sum of 3 quarters · filed 2023-02-28 | -$84.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$30.00K 10-Q · filed 2022-05-02 | -$50.28K derived: sum of 2 quarters · filed 2023-02-28 | -$65.13K derived: sum of 3 quarters · filed 2023-02-28 | -$66.56K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$20.29K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$35.13K derived: sum of 2 quarters · filed 2023-02-28 | -$36.56K derived: sum of 3 quarters · filed 2023-02-28 | -$45.89K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$14.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$16.27K derived: sum of 2 quarters · filed 2021-11-08 | -$25.60K 10-Q · filed 2021-11-08 | -$27.07K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$1.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$10.76K 10-Q · filed 2021-08-09 | -$12.22K derived: sum of 3 quarters · filed 2022-03-01 | -$15.42K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$9.33K 10-Q · filed 2021-05-10 | -$10.79K derived: sum of 2 quarters · filed 2022-03-01 | -$13.99K derived: sum of 3 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | -$1.46K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$4.66K derived: sum of 2 quarters · filed 2022-03-01 | -$16.12K 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | -$3.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$14.66K 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | -$11.46K 10-Q · filed 2020-08-10 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$8.48K derived: sum of 2 quarters · filed 2021-03-01 | -$18.12K derived: sum of 3 quarters · filed 2021-03-01 | -$32.70K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$8.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$18.12K derived: sum of 2 quarters · filed 2019-11-07 | -$32.70K 10-Q · filed 2019-11-07 | -$32.70K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$9.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$24.21K 10-Q · filed 2019-08-08 | -$24.22K derived: sum of 3 quarters · filed 2020-03-12 | -$27.82K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$14.58K 10-Q · filed 2019-05-09 | -$14.58K derived: sum of 2 quarters · filed 2020-03-12 | -$18.18K derived: sum of 3 quarters · filed 2020-03-12 | -$21.57K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$3.60K derived: sum of 2 quarters · filed 2020-03-12 | -$7.00K derived: sum of 3 quarters · filed 2020-03-12 | -$9.90K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$3.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$7.00K derived: sum of 2 quarters · filed 2018-11-09 | -$9.90K 10-Q · filed 2018-11-09 | -$15.95K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | -$3.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$6.29K 10-Q · filed 2018-08-08 | -$12.35K derived: sum of 3 quarters · filed 2019-03-15 | -$88.60K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | -$2.90K 10-Q · filed 2018-05-08 | -$8.95K derived: sum of 2 quarters · filed 2019-03-15 | -$85.21K derived: sum of 3 quarters · filed 2019-03-15 | -$96.81K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | -$6.05K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$82.31K derived: sum of 2 quarters · filed 2019-03-15 | -$93.91K derived: sum of 3 quarters · filed 2019-03-15 | -$104.56K 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | -$76.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$87.86K derived: sum of 2 quarters · filed 2017-11-08 | -$98.51K 10-Q · filed 2017-11-08 | -$102.62K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | -$11.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$22.25K 10-Q · filed 2017-08-09 | -$26.36K derived: sum of 3 quarters · filed 2018-03-07 | -$30.77K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | -$10.65K 10-Q · filed 2017-05-09 | -$14.76K derived: sum of 2 quarters · filed 2018-03-07 | -$19.17K derived: sum of 3 quarters · filed 2018-03-07 | -$20.59K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | -$4.11K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$8.52K derived: sum of 2 quarters · filed 2018-03-07 | -$9.94K derived: sum of 3 quarters · filed 2018-03-07 | -$20.20K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | -$4.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$5.83K derived: sum of 2 quarters · filed 2016-11-14 | -$16.08K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$1.42K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | -$11.68K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$10.26K 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |